Table 1.

Patient Characteristics (n=48)

Characteristic	Number of Patients
Age
<40	6
40–49	18
50–59	17
60–69	4
≥70	3
Performance Status
0	34
1	13
2	1
Race
White	38
Black	7
Asian	2
Hispanic	1
Prior Chemotherapy	48
Doxorubicin-based	43
Ifosfamide-based	3
Other (paclitaxel-cisplatin, temozolomide)	2
Prior Radiotherapy	17
Number of cycles received on study
1	5
2	7
3	3
4	7
5	2
6	5
7	5
>7	14